CEBP:XETRA:XETRA-iShares VII PLC - iShares MSCI EMU USD Hedged ETF Acc (EUR)

ETF | Others |

Last Closing

USD 9.83

Change

+0.01 (+0.08)%

Market Cap

USD 0.20B

Volume

165.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.37 (+0.84%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.23 (+0.25%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.12 (+0.51%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.07 (+0.56%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.04 (+0.73%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.15 (+0.66%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.02 (+0.15%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.76 (+1.35%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.03 (+0.34%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.16 (-0.13%)

USD 12.26B

ETFs Containing CEBP:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.20% 61% D- 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.20% 64% D 59% D-
Trailing 12 Months  
Capital Gain 2.91% 60% D- 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.91% 62% D 60% D-
Trailing 5 Years  
Capital Gain 91.88% 90% A- 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 91.88% 90% A- 84% B
Average Annual (5 Year Horizon)  
Capital Gain 15.81% 86% B+ 83% B
Dividend Return 15.81% 86% B+ 82% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.99% 62% D 70% C-
Risk Adjusted Return 158.27% 100% F 100% F
Market Capitalization 0.20B 52% F 40% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike